ÿþ<HTML><HEAD><TITLE>25º Congresso Brasileiro de Microbiologia </TITLE><link rel=STYLESHEET type=text/css href=css.css></HEAD><BODY aLink=#ff0000 bgColor=#FFFFFF leftMargin=0 link=#000000 text=#000000 topMargin=0 vLink=#000000 marginheight=0 marginwidth=0><table align=center width=700 cellpadding=0 cellspacing=0><tr><td align=left bgcolor=#cccccc valign=top width=550><font face=arial size=2><strong><font face=Verdana, Arial, Helvetica, sans-serif size=3><font size=1>25º Congresso Brasileiro de Microbiologia </font></font></strong><font face=Verdana size=1><b><br></b></font><font face=Verdana, Arial,Helvetica, sans-serif size=1><strong> </strong></font></font></td><td align=right bgcolor=#cccccc valign=top width=150><font face=arial size=2><strong><font face=Verdana, Arial, Helvetica, sans-serif size=1><font size=1>ResumoID:1992-1</font></em></font></strong></font></td></tr><tr><td colspan=2><br><br><table align=center width=700><tr><td>Área: <b>Micobacteriologa ( Divisão C )</b><p align=justify><strong><FONT FACE="ARIAL, HELVETICA, SANS-SERIF">THE ENZIME OROTATE PHOSPHORIBOSYLTRANSFERASE (OPRT) FROM <EM>MYCOBACTERIUM TUBERCULOSIS </EM>: BIOCHEMICAL CHARACTERIZATION AND GENE KNOCKOUT FOR AN ATTENUATED STRAIN DEVELOPMENT</FONT></strong></p><p align=justify><b><u>Ardala Breda </u></b> (<i>INCTT</i>); <b>Cristopher Zandoná Schneider </b> (<i>INCTT</i>); <b>Luiz Augusto Basso </b> (<i>INCTT</i>); <b>Diógenes Santiago Santos </b> (<i>INCTT</i>)<br><br></p><b><font size=2>Resumo</font></b><p align=justify class=tres><font size=2><P align=justify><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-fareast-language: PT-BR; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-bidi-language: AR-SA">Tuberculosis (TB) is a chronic infection mainly caused by <EM>Mycobacterium tuberculosis</EM> (MTB), killing over 2 million people annually. TB resurgence and&nbsp;multi and extensive-drug resistant strains leads to the need of novel TB treatments. The orotate phosphoribosyltransferase (OPRT) catalyses OMP formation, the fifth reaction of the <EM>de novo</EM> synthesis of pyrimidine nucleotides, an essential pathway for microorganism viability; and is an attractive antitubercular drug target.</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-fareast-language: PT-BR; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-GB; mso-bidi-language: AR-SA"> </SPAN><SPAN lang=EN-GB style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-fareast-language: PT-BR; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-GB; mso-bidi-language: AR-SA">The aims of this study were: I. A</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-fareast-language: PT-BR; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-bidi-language: AR-SA">mplification and cloning of the </SPAN><SPAN lang=EN-GB style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-fareast-language: PT-BR; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-GB; mso-bidi-language: AR-SA">OPRT coding </SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-fareast-language: PT-BR; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-bidi-language: AR-SA"><EM>pyrE</EM> gene, overexpression and purification of the recombinant enzyme for further biochemical characterization. II. To </SPAN><SPAN lang=EN-GB style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-fareast-language: PT-BR; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-GB; mso-bidi-language: AR-SA">knockout the <SPAN style="mso-bidi-font-style: italic"><EM>pyrE</EM></SPAN> gene, leading to a MTB strain dependent of pyrimidine salvage pathway to suffice its anabolic needs for such nucleotides. </SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-fareast-language: PT-BR; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-bidi-language: AR-SA">The full-length <EM>pyrE</EM> coding region was amplified from MTB genome and cloned at the expression vector pET-23a+. Resulting plasmid was introduced into the <EM>E. coli</EM> BL21(DE3) strain and grown in LB medium at 37°C. Best protein expression was obtained after 12h with 1mM IPTG induction. Recombinant OPRT was purified with anion exchange and size exclusion liquid chromatography columns using a FPLC system, with purity higher than 92%. The oligomeric state determination by size exclusion liquid chromatography showed that MTB OPRT is formed by two identical subunits of 21 KDa each. OPRT activity (OMP synthesis) was measured spectrophotometrically for kinetic constants determination, allowing a better understanding of pyrimidine metabolism of mycobacteria. For gene knockout experiments, nucleotide lengths of 1Kb upstream and downstream of <EM>pyrE</EM> gene were independently amplified from MTB genome and cloned into pCR-Blunt vectors. Both fragments were digested with appropriated enzymes and cloned into a p2NIL vector. Resistance markers were introduced into the p2NIL vector, allowing visual selection of proper knockout constructs plasmids, as well as MTB cells where homology recombination process has occurred. Obtained knockout MTB cells will be grown with uracil supplementation and tested for its infection and immunogenic capabilities. An MTB strain unable to catalyze de novo synthesis of pyrimidines will </SPAN><SPAN lang=EN-GB style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-fareast-language: PT-BR; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-GB; mso-bidi-language: AR-SA">expected</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-fareast-language: PT-BR; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-bidi-language: AR-SA"> to constitute an attenuated strain, capable of</SPAN><SPAN lang=EN-GB style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-fareast-language: PT-BR; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-GB; mso-bidi-language: AR-SA"> inducing a long-term protective immune response to TB infection</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-fareast-language: PT-BR; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-bidi-language: AR-SA">.</SPAN></P></font></p><br><b>Palavras-chave: </b>&nbsp;Mycobacterium tuberculosis, nucleotide metabolism, Orotate Phosphoribosyltransferase, pyrimidine metabolism</td></tr></table></tr></td></table></body></html>